Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Janice M. Lage"'
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 13, Iss 1, Pp 49-52 (2005)
A 40-year-old woman, gravida 9, with seven healthy children and a history of one abortion (p 7 + 1) , presented at 18 weeks of gestation with fever and malodorous vaginal discharge. Ultrasound revealed a macerated fetus. The placenta showed acute cho
Externí odkaz:
https://doaj.org/article/2c29d616410d4d6cac7780ad8a706a61
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 13, Iss 1, Pp 49-52 (2005)
A 40-year-old woman, gravida 9, with seven healthy children and a history of one abortion (p 7 + 1) , presented at 18 weeks of gestation with fever and malodorous vaginal discharge. Ultrasound revealed a macerated fetus. The placenta showed acute cho
Externí odkaz:
https://doaj.org/article/1e59a9b2018948b88f2b311b32524567
Autor:
Elizaveta Chernetsova, Harman Sekhon, Shahidul Islam, Kianoosh Keyhanian, Zohreh Eslami, Janice M. Lage
Publikováno v:
International Journal of Gynecological Pathology. 39:354-361
Our objective was to evaluate the diagnostic utility of 2 new proliferation markers, cyclin D1 and minichromosome maintenance complex component 2 (MCM2), in comparison with p16, p53, and Ki67 in differentiating the spectrum of smooth muscle tumors. A
Autor:
Nasir A. Butt, Israh Akhtar, Anait S. Levenson, Swati Dhar, Avinash Kumar, Janice M. Lage, John C. Hancock, Charles R. Pound, Jack R. Lewin, Agnes M. Rimando, Christian R. Gomez
Publikováno v:
Cancer Medicine
The metastasis‐associated protein 1(MTA1)/histone deacetylase (HDAC) unit is a cancer progression‐related epigenetic regulator, which is overexpressed in hormone‐refractory and metastatic prostate cancer (PCa). In our previous studies, we found
Autor:
Israh Akhtar, John C. Hancock, Swati Dhar, Anait S. Levenson, Avinash Kumar, Janice M. Lage, Christian R. Gomez, Charles R. Pound
Publikováno v:
FEBS Letters. 591:924-933
We have previously shown that metastasis-associated protein 1 (MTA1), a chromatin remodeler, plays an important role in prostate cancer invasiveness, likely through regulation of epithelial-to-mesenchymal transition. Here, we identified miR-22 as an
Autor:
Erin Harrison, Janice M. Lage, Thomas Rousselle, Ramachandram Avusula, Jonathan W. Lee, Yongzhen Gong, Xiu Liu, Meiyu Zhang, Lisa Biswas
Publikováno v:
Psychopharmacology. 233:3417-3427
Tobacco smoking is a leading preventable cause of premature death in the USA. Menthol is a significant flavoring additive in tobacco products. Clinical evidence suggests that menthol may promote tobacco smoking and nicotine dependence. However, it is
Autor:
Azeddine Atfi, Liangfen Zhang, Swati Dhar, Jack R. Lewin, Anait S. Levenson, Janice M. Lage, Xu Zhang, Avinash Kumar, Agnes M. Rimando
Publikováno v:
Oncotarget
Overexpression of the epigenetic modifier metastasis-associated protein 1 (MTA1) is associated with aggressive human prostate cancer. The purpose of this study was to determine MTA1- targeted chemopreventive and therapeutic efficacy of pterostilbene,
Autor:
Xu Zhang, Jack R. Lewin, Avinash Kumar, Agnes M. Rimando, Swati Dhar, Janice M. Lage, Anait S. Levenson
Publikováno v:
Annals of the New York Academy of Sciences. 1348:1-9
Lifestyle, particularly diet, is a risk factor for prostate cancer. Dietary polyphenols such as resveratrol possess anticancer properties and therefore have chemopreventive and therapeutic potential. Resveratrol has pleiotropic effects, exerting its
Publikováno v:
Experimental and Molecular Pathology. 97:259-265
Aims Five sphingosine-1-phosphate receptors (S1PR): S1PR1, S1PR2, S1PR3, S1PR4 and S1PR5 (S1PR1–5) have been shown to be involved in the proliferation and progression of various cancers. However, none of the S1PRs have been systemically investigate
Autor:
David Miller, Angeles Alvarez Secord, Virginia L. Filiaci, Janice M. Lage, Julian C. Schink, Joseph L. Kelley, Raymond Osborne, Robert S. Mannel, Diane Provencher, Allan Covens
Publikováno v:
Journal of Clinical Oncology. 29:825-831
Purpose There is no consensus on the best regimen for the primary treatment of low-risk gestational trophoblastic neoplasia (GTN). Patients and Methods Two commonly used single-drug regimens were compared with respect to the proportion of patients me